Autoimmunity Research Inc is a nonprofit organization focused on Medical Research, based in THOUSAND OAKS, CA. IRS filing data is available from 2020 through 2024. As of 2024, the organization holds $321K in total assets.
Financial Overview
From 2024 IRS Form 990-PF · View filing
Total Assets
$321K
-18.5% YoY
Revenue
$4K
-12.2% YoY
Net Investment Income
—
Expenses
$76K
+4.1% YoY
About Autoimmunity Research Inc
Based on IRS filings
Autoimmunity Research Inc is a nonprofit organization focused on Medical Research, based in THOUSAND OAKS, CA. IRS filing data is available from 2020 through 2024. As of 2024, the organization holds $321K in total assets.
Focus Areas
Ready to take the next step with Autoimmunity Research Inc?
Geographic Focus
Where this funder awards grants
Grant Distribution by State
States
Cities
Financial History
Multi-year comparison from IRS filings
| Metric | 2024 | 2023 | 2022 |
|---|---|---|---|
| Total Assets | $321,472 | $394,389 | $463,829 |
| Revenue | $3,524 | $4,014 | $1,149 |
| Expenses | $76,406 | $73,396 | $184,777 |
| Qualifying Distributions | — | — | — |
| Net Investment Income | — | — | — |
| Distributable Amount | — | — | — |
Giving Over Time
Total grant dollars and number of grants per year
Grant Insights
How this funder distributes its grants
Top Recipients
Top 0 recipients in 2024
Grant Size Distribution
1 grants across all recorded years
Giving History
Grant recipients and amounts by year
No grants recorded for 2024.
Leadership & Key People
Officers and directors from IRS filings
Compensation Overview
From 2024 IRS filing
From 2024 filing
| Name | Title | Hours | Compensation |
|---|---|---|---|
| Trevor G Marshall | CEO, Chairman of Board | 10 | — |
| Frances Marshall | CFO, Director | 5 | — |
| Mary Sue Mistler | Director | 1 | — |
| Trudy J Behrendsen | Director | 1 | — |
| Veny Musum | Director | 1 | — |
Subject Areas
Focus areas based on grantmaking activity
Frequently Asked Questions
What is Autoimmunity Research Inc?
Autoimmunity Research Inc is a nonprofit organization focused on Medical Research, based in THOUSAND OAKS, CA. It holds $321K in total assets as of 2024.
How large is Autoimmunity Research Inc?
As of 2024, Autoimmunity Research Inc holds $321K in total assets with $4K in annual revenue.
Where does Autoimmunity Research Inc operate?
Autoimmunity Research Inc has awarded grants in Washington.
What is Autoimmunity Research Inc's EIN?
Autoimmunity Research Inc's EIN (Employer Identification Number) is 20-1137851. IRS Form 990 filing data is available on this page for 2020–2024.
Explore Open Grants
Browse active grant opportunities in Autoimmunity Research Inc's focus areas in our free grants database
Similar Funders
Funders that support many of the same organizations
Isola Charities
MERCER ISLAND, WA
Assets
$2K
Grants
8
Total Given
$47K
Robert and Ruth Halperin Foundation
SAN FRANCISCO, CA
Assets
$151.4M
Grants
54
Total Given
$7.8M
Doty Family Foundation
NEW YORK, NY
Assets
$2.9M
Grants
134
Total Given
$577K
The New York Community Trust
NEW YORK, NY
Assets
$3.5B
Grants
2,748
Total Given
$193.8M
Network for Good
WASHINGTON, DC
Assets
$96.2M
Grants
4,733
Total Given
$216.2M
National Philanthropic Trust
JENKINTOWN, PA
Assets
$42.2B
Grants
18,583
Total Given
$5.1B
Wallace Research Foundation
CEDAR RAPIDS, IA
Assets
—
Grants
34
Total Given
$4.4M
Donovan-hale Family Foundation
WAYLAND, MA
Assets
$492K
Grants
1
Total Given
$25K
Tisbest Philanthropy
SEATTLE, WA
Assets
$2.2M
Grants
181
Total Given
$3.8M
Silicon Valley Community Foundation
MOUNTAIN VIEW, CA
Assets
$12.3B
Grants
3,576
Total Given
$3.2B
Tides Foundation
SAN FRANCISCO, CA
Assets
$534.5M
Grants
2,110
Total Given
$382.1M
California Community Foundation
LOS ANGELES, CA
Assets
$2.2B
Grants
2,025
Total Given
$272.6M
Data last updated April 2026. Sourced from IRS Form 990-PF filings.
What could you do with Autoimmunity Research Inc on Grantable?
- Assess strategic fit with your organization
- Draft a tailored letter of inquiry
- Find open RFPs from this funder
- Monitor for new funding opportunities
Go from researching Autoimmunity Research Inc to a real strategy.